Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.
about
In vitro effects of folate inhibitors on Toxoplasma gondiiAnti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniquesIn vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondiiLocalization of azithromycin in Toxoplasma gondii-infected cellsHigh-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitroImpact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosisLevels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study GroupIdentification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE)Simple and efficient model systems of screening anti-Toxoplasma drugs in vitro.In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium sppIn situ enzyme-linked immunosorbent assay to quantitate in vitro development of Eimeria tenella.In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target?In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii
P2860
Q28342121-1DC79D3F-4655-4D39-BC33-D197476757E2Q28344751-9B9662CA-AFB1-4267-B73E-C5BEE2834FB1Q28379243-202DF6F8-B363-4547-BE05-5577440A45E6Q33755229-F9EF6038-1B83-44E0-BA15-083CEAF4D67FQ34725225-A9884C7F-57BF-49B2-965A-14D4D6065D64Q35137900-53E5479B-AB15-4ABD-A8E2-41BC86EF77A1Q35690063-82312A2D-36A7-459D-AD59-89C9D9DB56BDQ35826163-B47E8065-784E-42A8-BB6A-BFEC031C447CQ35836203-2F5C4161-E8C0-4CDC-A5D8-69B11D1C4A5EQ37390610-D5774A5D-3858-4C69-9CAA-25634D12BF09Q37999103-9A3FD70F-5DFE-4680-BBAD-CDC6386191D1Q39792650-1C6AD669-20F9-4653-9B3F-BEBDD0B718DFQ39832809-7108509F-4478-4BC1-BE31-BAD5B1D22D0DQ39882492-F6A7B8F9-40B5-42FF-9988-132A093FFC81Q40165651-399B02AA-5C8B-4B10-BEB7-9FB1CCEE0D44Q40865388-21D58C34-53D2-4E98-A6AC-8F1097E0CE7AQ41831157-C7B9AB4C-28FC-459C-AA76-E21334673419Q41911094-C90A3B6F-82A3-455E-9AE0-52F6FA6B1F80Q42757419-602DA730-461B-4A28-86FA-95FE1F31CDE9
P2860
Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@en
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@nl
type
label
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@en
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@nl
prefLabel
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@en
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@nl
P2860
P356
P1476
Enzyme immunoassay to assess e ...... asma gondii in tissue culture.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.3.303
P407
P577
1988-03-01T00:00:00Z